ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2023, 'Novel biofabrication approaches enabled by di-tyrosine crosslinking of silk fibroin', in TISSUE ENGINEERING PART A, MARY ANN LIEBERT, INC, ENGLAND, Manchester, presented at Meeting of the European-Chapter of the Tissue-Engineering-and-Regenerative-Medicine-International-Society (TERMIS), ENGLAND, Manchester, 28 March 2023 - 31 March 2023
,2022, 'Biofabrication approaches enabled by covalent crosslinking of silk', in TISSUE ENGINEERING PART A, MARY ANN LIEBERT, INC, SOUTH KOREA, Jeju, pp. 206 - 206, presented at Tissue-Engineering-and-Regenerative-Medicine-International-Society-Asia-Pacific-Chapter Conference (TERMIS-AP), SOUTH KOREA, Jeju, 05 October 2022 - 08 October 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000899413100193&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,